ALK-Abelló AG
ALK-Abelló AG is a Biotech company based in Volketswil (Zurich) recorded by Swissmedic as the authorisation holder for 23 human medicines. That places it 82 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Allergen: Therapeutikum.
Key facts
| Sector | Biotech |
|---|---|
| City | Volketswil |
| Canton | Zurich |
| Authorisation holder | Yes |
| Medicines | 23 |
| Founded | Not available |
| Employees | 11-50 |
| Parent group | ALK-Abelló A/S |
| Activity | Not available |
| Website | alk.net |
Medicines authorised in Switzerland
No medicine authorisation
ALK-Abelló AG is not recorded as an authorisation holder for human medicines with Swissmedic. That is normal for device manufacturers, contract manufacturers, wholesalers, laboratories and consultancies.
Biotechnological products, blood products, vaccines, cell and gene therapies and allergens.
Frequently asked questions
How many medicines does ALK-Abelló AG have authorised in Switzerland?
ALK-Abelló AG is recorded by Swissmedic as the authorisation holder for 23 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is ALK-Abelló AG based?
The Swiss location recorded for ALK-Abelló AG is Volketswil, Zurich.
Is ALK-Abelló AG a Swissmedic authorisation holder?
Yes. ALK-Abelló AG appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.